GlassScriptPhysician profile
Seung Won Kim
NPI 1205032984
$9,633.17
in general payments reported to CMS, 2019-2025
42 companies · $18.03 in 2025
The $18.03 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,694 · 2020: $883 · 2021: $3,795 · 2022: $657 · 2023: $1,017 · 2024: $1,569 · 2025: $18.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,290.35 | 2019-2023 | |
| Forte Bio-Pharma LLC | $778.55 | 2019-2024 | Prolate, Nalocet |
| Collegium Pharmaceutical, INC. | $754.14 | 2019-2024 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $541.13 | 2019-2025 | Relistor |
| Indivior INC. | $372.21 | 2019-2024 | Sublocade |
| Medtronic, INC. | $352.28 | 2022-2024 | Intellis Adaptivestim |
| Valinor Pharma, LLC | $346.11 | 2024 | Movantik |
| Scilex Pharmaceuticals INC. | $339.33 | 2020-2024 | Ztlido |
| Braeburn INC. | $332.02 | 2023-2024 | Brixadi |
| Daiichi Sankyo INC. | $300.13 | 2019 | |
| Biodelivery Sciences International, INC. | $243.32 | 2019-2021 | |
| Abbott Laboratories | $207.69 | 2019-2021 | |
| Orexo US, INC. | $198.86 | 2023-2024 | Zubsolv |
| Takeda Pharmaceuticals U.S.A., INC. | $192.45 | 2019-2020 | |
| Pfizer INC. | $142.13 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seung Won Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.